Struggling gene therapy developer Bluebird bio is again cutting costs, announcing Tuesday a plan to lay off about a quarter of its workforce to reduce spending. In a statement, Bluebird said it turned ...

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%.

Somerville gene therapy company Bluebird Bio on Tuesday announced a 25 percent reduction of its workforce as part of a restructuring meant to save money as it seeks to market its expensive but ...

September 24, 2024--(BUSINESS WIRE)--Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is implementing a restructuring intended ...

The best garden rakes make the task of raking the leaves feel easy; effortlessly gliding through piles of roughage in every type of weather. We researched dozens of brands, reviewed hundreds of ...

Back in 2019 and early 2020, bluebird bio stock was between $40 and $50 a share, and the latest quote is 48 cents. This despite getting three gene therapies on the market. Two of bluebird bio’s ...

Some experts have recommended for years now that we leave the leaves where they land and a new survey shows more Americans may be fighting the urge to rake and bag autumn's bounty. A National ...

Newly published data show that seven out of 67 children who received Bluebird Bio’s gene therapy for a devastating neurological disorder in clinical trials have since gone on to develop blood ...